High-resolution melting analysis of ADAMTS9 methylation levels in gastric, colorectal, and pancreatic cancers

Cancer Genetics and Cytogenetics

Volumn 196, Issue 1, 2010, Pages 38-44

  Zhang, Chao ^a   Shao, Yong ^a,b   Zhang, Wei ^c   Wu, Qi ^a   Yang, Hong ^a,b   Zhong, Qili ^b   Zhang, Jie ^b   Guan, Ming ^d   Yu, Bo ^a,b   Wan, Jun ^a,e  

^a Biomedical Research Institute   (China)

^b PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^c JINAN UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

^e HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

A DISINTEGRIN AND METALLOPROTEASE WITH THROMBOSPONDIN MOTIF; METALLOPROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETIC PROCEDURES; HIGH RESOLUTION MELTING ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN METHYLATION; SENSITIVITY ANALYSIS; STOMACH CANCER;

ADAM PROTEINS; BASE SEQUENCE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA PRIMERS; HUMANS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 70949102966     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.08.016     Document Type: Article

References (35)

1. Apte S.S. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 36 (2004) 981-985
2. Lopez-Otin C., and Matrisian L.M. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7 (2007) 800-808
3. Porter S., Clark I.M., Kevorkian L., and Edwards D.R. The ADAMTS metalloproteinases. Biochem J 386 (2005) 15-27
4. Rocks N., Paulissen G., El Hour M., Quesada F., Crahay C., Gueders M., Foidart J.M., Noel A., and Cataldo D. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 90 (2008) 369-379
5. Tang B.L. ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol 33 (2001) 33-44
6. Tortorella M.D., Burn T.C., Pratta M.A., Abbaszade I., Hollis J.M., Liu R., Rosenfeld S.A., Copeland R.A., Decicco C.P., Wynn R., Rockwell A., Yang F., Duke J.L., Solomon K., George H., Bruckner R., Nagase H., Itoh Y., Ellis D.M., Ross H., Wiswall B.H., Murphy K., Hillman Jr. M.C., Hollis G.F., Newton R.C., Magolda R.L., Trzaskos J.M., and Arner E.C. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284 (1999) 1664-1666
7. Tortorella M.D., Liu R.Q., Burn T., Newton R.C., and Arner E. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 21 (2002) 499-511
8. Kuno K., Okada Y., Kawashima H., Nakamura H., Miyasaka M., Ohno H., and Matsushima K. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 478 (2000) 241-245
9. Demircan K., Hirohata S., Nishida K., Hatipoglu O.F., Oohashi T., Yonezawa T., Apte S.S., and Ninomiya Y. ADAMTS-9 is synergistically induced by interleukin-1β and tumor necrosis factor α in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 52 (2005) 1451-1460
10. Dunn J.R., Reed J.E., du Plessis D.G., Shaw E.J., Reeves P., Gee A.L., Warnke P., and Walker C. Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours. Br J Cancer 94 (2006) 1186-1193
11. Vázquez F., Hastings G., Ortega M.A., Lane T.F., Oikemus S., Lombardo M., and Iruela-Arispe M.L. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 274 (1999) 23349-23357
12. Llamazares M., Obaya A.J., Moncada-Pazos A., Heljasvaara R., Espada J., López-Otín C., and Cal S. The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway. J Cell Sci 120 (2007) 3544-3552
13. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8 (2007) 286-298
14. Jin H., Wang X., Ying J., Wong A.H., Li H., Lee K.Y., Srivastava G., Chan A.T., Yeo W., Ma B.B., Putti T.C., Lung M.L., Shen Z.Y., Xu L.Y., Langford C., and Tao Q. Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene 26 (2007) 7490-7498
15. Lind G.E., Kleivi K., Meling G.I., Teixeira M.R., Thiis-Evensen E., Rognum T.O., and Lothe R.A. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol 28 (2006) 259-272
16. Viloria C.G., Obaya A.J., Moncada-Pazos A., Llamazares M., Astudillo A., Capella G., Cal S., and Lopez-Otin C. Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer. Cancer Res 69 (2009) 4926-4934
17. Lo P.H., Leung A.C., Kwok C.Y., Cheung W.S., Ko J.M., Yang L.C., Law S., Wang L.D., Li J., Stanbridge E.J., Srivastava G., Tang J.C., Tsao S.W., and Lung M.L. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene 26 (2007) 148-157
18. Lung H.L., Lo P.H., Xie D., Apte S.S., Cheung A.K., Cheng Y., Law E.W., Chua D., Zeng Y.X., Tsao S.W., Stanbridge E.J., and Lung M.L. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer 123 (2008) 401-408
19. Wojdacz T.K., Dobrovic A., and Hansen L.L. Methylation-sensitive high-resolution melting. Nat Protoc 3 (2008) 1903-1908
20. Virmani A.K., Tsou J.A., Siegmund K.D., Shen L.Y., Long T.I., Laird P.W., Gazdar A.F., and Laird-Offringa I.A. Hierarchical clustering of lung cancer cell lines using DNA methylation markers. Cancer Epidemiol Biomarkers Prev 11 (2002) 291-297
21. Wittwer C.T., Reed G.H., Gundry C.N., Vandersteen J.G., and Pryor R.J. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 49 (2003) 853-860
22. Paz M.F., Fraga M.F., Avila S., Guo M., Pollan M., Herman J.G., and Esteller M. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 63 (2003) 1114-1121
23. INK4B CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94 (1999) 2445-2451
24. Hsieh C.L. Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 14 (1994) 5487-5494
25. Taback B., Giuliano A.E., Lai R., Hansen N., Singer F.R., Pantel K., and Hoon D.S. Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients. Ann N Y Acad Sci 1075 (2006) 211-221
26. Sobin L.H., Wittekind C., and International Union Against Cancer (UICC). TNM classification of malignant tumours. 6th ed (2002), Wiley-Liss, New York
27. -ΔΔCT method. Methods 25 (2001) 402-408
28. Schmittgen T.D., and Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3 (2008) 1101-1108
29. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93 (1996) 9821-9826
30. Clark S.J., Harrison J., Paul C.L., and Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22 (1994) 2990-2997
31. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., and Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89 (1992) 1827-1831
32. Colella S., Shen L., Baggerly K.A., Issa J.P., and Krahe R. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 35 (2003) 146-150
33. Warnecke P.M., Stirzaker C., Melki J.R., Millar D.S., Paul C.L., and Clark S.J. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 25 (1997) 4422-4426
34. Wojdacz T.K., and Hansen L.L. Reversal of PCR bias for improved sensitivity of the DNA methylation melting curve assay. Biotechniques 41 (2006) 274-278
35. Kwabi-Addo B., Chung W., Shen L., Ittmann M., Wheeler T., Jelinek J., and Issa J.P. Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res 13 (2007) 3796-3802